Allspring Global Investments Holdings, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$41,539,988
+30.0%
261,240
+37.7%
0.07%
+39.6%
Q1 2023$31,945,804
-37.5%
189,747
-37.2%
0.05%
-39.1%
Q4 2022$51,128,232
-37.8%
301,980
-31.3%
0.09%
-40.4%
Q3 2022$82,219,000
-7.6%
439,423
-19.8%
0.15%
-2.0%
Q2 2022$89,003,000
-22.4%
548,050
-10.1%
0.15%
+2.8%
Q1 2022$114,696,000
-47.5%
609,800
-26.1%
0.14%
-40.3%
Q4 2021$218,643,000825,5720.24%
Other shareholders
REPLIGEN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders